期刊文献+

IgA肾病的药物治疗进展

在线阅读 下载PDF
导出
摘要 近来研究发现,IgA。肾病约有15%~20%的患者在发病10年内进入终末期-肾衰竭,30%~40%的患者在发病20年内进入终末期肾衰竭。IgAN的诊断主要依靠。肾活检,免疫荧光示。肾小球系膜区存在IgA或以IgA为主的免疫复合物沉积。因其发病机制尚未明确,目前尚无特效的治疗方法,临床仍处于缓解症状及经验性治疗。本文将近年的治疗研究进展综述如下。
作者 张饰 丁国华
出处 《临床肾脏病杂志》 2005年第6期284-286,共3页 Journal Of Clinical Nephrology
  • 相关文献

参考文献21

  • 1石晓云,陈香美,刘述文,庄永泽,张燕平.血管紧张素转换酶抑制剂对IgA肾病的疗效及影响因素分析[J].中华内科杂志,2002,41(6):399-403. 被引量:40
  • 2Praga M, Gutierrez E, Gonzalez E, et al.Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol, 2003, 14:1578-1583.
  • 3Chen X, Qiu Q, Tang L, et al. Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant, 2004,19 : 852 857.
  • 4Iimura O,Kusano E,Tanba K,et al. Additive antiproteinuric effect of angiotensin Ⅱ receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis. Nippon Jinzo Gakkai Shi, 2003,45 : 439-444.
  • 5Yang Y, Ohta K, Shimizu M, et al. Treatment with low-dose angiotensin-converring enzyme inhibitor(ACEI) plus angiotensin Ⅱ receptor blocker(ARB) in pediatric patients with IgA nephropathy. Clin Nephrol, 2005,64 : 35-40.
  • 6Tanaka H, Suzuki K, Nakahata T, et al.Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int, 2004,46: 576-579.
  • 7Pozzi C, Andrulli S, Del Vecchio L. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized,controlled trial. J Am Soc Nephrol, 2004,15:157-163.
  • 8Moriyama T, Honda K,Nitta K,et al. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol, 2004,8 : 237-242.
  • 9Donadio JV Jr, Grande JP,Bergstralh EJ,et al. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. J Am Soc Nephrol,1999,10 ; 1772-1777.
  • 10Donadio JV, Larson TS,Bergstralh EJ,et al. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol, 2001,12 : 791-799.

二级参考文献10

  • 1Coppo R, Amore A, Gianoglio B,et al. Angiotensin Ⅱ local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis, 1993, 21:593-602.
  • 2Lee SM, Rao VM, Franklin WA, et al. IgA Nephropathy: morphologic predictors of progressive renal disease. Hum Pathol ,1982, 13:314-322.
  • 3Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol, 1998, 49:1-8.
  • 4Maschio G, Alberti D, Janin G, et al. Effecrt of the angiotensin-converting enzyme inhibitor benezepril on the progression of chronic renal insufficiency. The angiotensin-converting enzyme inhibition in progressive renal insufficiency study group. N Engl J Med ,1996, 334:939-945.
  • 5Dillon JJ. ACE inhibitor therapy for IgA nephropathy: a meta analysis. J Am Soc Nephrol ,1998, 9:86A.
  • 6Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition . Am J Kidney Dis, 1991, 17:330-338.
  • 7Myers BD, Meyer TW. Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy. Am J Kidney Dis, 1989, 13:20-24.
  • 8Don BR, Kaysen GA, Hutchison FN, et al. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis, 1991, 17:10-17.
  • 9Ikoma M, Kawamura T, Kakinuma Y, et al. Cause of variable therapeutic efficiency of angiotensin-converting enzyme inhibitors on glomerular lesions. Kidney Int, 1991, 40:195-202.
  • 10庄永泽,陈香美,张燕平,危成筠,石晓云,童新元,张高魁.540例IgA肾病高血压发生影响因素的分析[J].中华内科杂志,2000,39(6):371-375. 被引量:33

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部